P166-1310 Screening compound: 1-(furan-2-carbonyl)-4-({3-[6-(pyrrolidin-1-yl)pyridin-3-yl]-1,2,4-oxadiazol-5-yl}methyl)piperazine

P166-1310 Screening compound: 1-(furan-2-carbonyl)-4-({3-[6-(pyrrolidin-1-yl)pyridin-3-yl]-1,2,4-oxadiazol-5-yl}methyl)piperazine
P166-1310 Screening compound: 1-(furan-2-carbonyl)-4-({3-[6-(pyrrolidin-1-yl)pyridin-3-yl]-1,2,4-oxadiazol-5-yl}methyl)piperazine alternative view

Chemical Structure Depiction of ChemDiv screening compound P166-1310
1-(furan-2-carbonyl)-4-({3-[6-(pyrrolidin-1-yl)pyridin-3-yl]-1,2,4-oxadiazol-5-yl}methyl)piperazine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P166-1310

Molecular Formula

C21H24N6O3 (C21 H24 N6 O3)

Compound Name

1-(furan-2-carbonyl)-4-({3-[6-(pyrrolidin-1-yl)pyridin-3-yl]-1,2,4-oxadiazol-5-yl}methyl)piperazine

IUPAC name

1-(furan-2-carbonyl)-4-({3-[6-(pyrrolidin-1-yl)pyridin-3-yl]-124-oxadiazol-5-yl}methyl)piperazine

SMILES

O=C(c1ccco1)N1CCN(Cc2nc(-c(cc3)cnc3N3CCCC3)no2)CC1

InChI

InChI=1S/C21H24N6O3/c28-21(17-4-3-13-29-17)27-11-9-25(10-12-27)15-19-23-20(24-30-19)16-5-6-18(22-14-16)26-7-1-2-8-26/h3-6,13-14H,1-2,7-12,15H2

InChI Key

IZYOSFLCVJMQFT-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27567349

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

408.46

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

2.390

Distribution Coefficient, logD

1.493

Water Solubility, LogSw

-2.45

Polar Surface Area

72.768

Acid Dissociation Constant (pKa)

23.40

Base Dissociation Constant (pKb)

8.24

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

42.90

P166-1310 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

Anti-HIV1 Library (19540 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Antiviral
  • Infections
  • Immune system
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with P166-1310 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P166-1310?
Check Price and Availability of P166-1310, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P166-1310 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P166-1310
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P166-1310
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P166-1310 available by request